Glaukos Corp Stock Beta
| GKOS Stock | USD 109.79 0.62 0.56% |
Glaukos Corp fundamentals help investors to digest information that contributes to Glaukos Corp's financial success or failures. It also enables traders to predict the movement of Glaukos Stock. The fundamental analysis module provides a way to measure Glaukos Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Glaukos Corp stock.
Glaukos | Beta |
Glaukos Corp Company Beta Analysis
Glaukos Corp's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Glaukos Corp Beta | 1.08 |
Most of Glaukos Corp's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Glaukos Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Glaukos Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Glaukos Corp is extremely important. It helps to project a fair market value of Glaukos Stock properly, considering its historical fundamentals such as Beta. Since Glaukos Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Glaukos Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Glaukos Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Glaukos Corp has a Beta of 1.084. This is 26.05% higher than that of the Health Care Equipment & Supplies sector and 4.23% higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Glaukos Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Glaukos Corp's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Glaukos Corp could also be used in its relative valuation, which is a method of valuing Glaukos Corp by comparing valuation metrics of similar companies.Glaukos Corp is currently under evaluation in beta category among related companies.
Glaukos Corp ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Glaukos Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Glaukos Corp's managers, analysts, and investors.Environmental | Governance | Social |
Glaukos Corp Institutional Holders
Institutional Holdings refers to the ownership stake in Glaukos Corp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Glaukos Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Glaukos Corp's value.| Shares | Millennium Management Llc | 2023-12-31 | 1 M | Geode Capital Management, Llc | 2023-12-31 | 1 M | Dimensional Fund Advisors, Inc. | 2023-12-31 | 923.5 K | Primecap Management Company | 2023-12-31 | 790 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 662.3 K | Driehaus Capital Management Llc | 2023-12-31 | 588.9 K | Capital World Investors | 2023-12-31 | 550.3 K | Northern Trust Corp | 2023-12-31 | 542.7 K | Riverbridge Partners Llc | 2024-03-31 | 534.5 K | Blackrock Inc | 2023-12-31 | 7.9 M | Fmr Inc | 2023-12-31 | 5.8 M |
Glaukos Corp returns are very sensitive to returns on the market. As the market goes up or down, Glaukos Corp is expected to follow.
Glaukos Fundamentals
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.0795 | ||||
| Profit Margin | (0.43) % | ||||
| Operating Margin | (0.32) % | ||||
| Current Valuation | 5.67 B | ||||
| Shares Outstanding | 50.37 M | ||||
| Shares Owned By Insiders | 3.48 % | ||||
| Shares Owned By Institutions | 96.52 % | ||||
| Number Of Shares Shorted | 3.51 M | ||||
| Price To Earning | 94.70 X | ||||
| Price To Book | 10.52 X | ||||
| Price To Sales | 15.44 X | ||||
| Revenue | 314.71 M | ||||
| Gross Profit | 213.88 M | ||||
| EBITDA | (82.12 M) | ||||
| Net Income | (134.66 M) | ||||
| Cash And Equivalents | 391.19 M | ||||
| Cash Per Share | 8.22 X | ||||
| Total Debt | 383.74 M | ||||
| Debt To Equity | 0.68 % | ||||
| Current Ratio | 6.78 X | ||||
| Book Value Per Share | 9.04 X | ||||
| Cash Flow From Operations | (57.76 M) | ||||
| Short Ratio | 7.03 X | ||||
| Earnings Per Share | (2.88) X | ||||
| Price To Earnings To Growth | 1.64 X | ||||
| Target Price | 112.73 | ||||
| Number Of Employees | 907 | ||||
| Beta | 1.08 | ||||
| Market Capitalization | 5.56 B | ||||
| Total Asset | 940.41 M | ||||
| Retained Earnings | (599.07 M) | ||||
| Working Capital | 321.45 M | ||||
| Current Asset | 104.14 M | ||||
| Current Liabilities | 20.36 M | ||||
| Net Asset | 940.41 M |
About Glaukos Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Glaukos Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Glaukos Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Glaukos Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Glaukos Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Glaukos Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Glaukos Corp will appreciate offsetting losses from the drop in the long position's value.Moving against Glaukos Stock
| 0.87 | CVS | CVS Health Corp | PairCorr |
| 0.79 | ENSG | Ensign Group | PairCorr |
| 0.74 | DOCS | Doximity Upward Rally | PairCorr |
| 0.74 | VEEV | Veeva Systems Class Financial Report 29th of May 2024 | PairCorr |
| 0.55 | COO | Cooper Companies Financial Report 6th of June 2024 | PairCorr |
The ability to find closely correlated positions to Glaukos Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Glaukos Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Glaukos Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Glaukos Corp to buy it.
The correlation of Glaukos Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Glaukos Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Glaukos Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Glaukos Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Glaukos Corp Piotroski F Score and Glaukos Corp Altman Z Score analysis. For more information on how to buy Glaukos Stock please use our How to Invest in Glaukos Corp guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Glaukos Stock analysis
When running Glaukos Corp's price analysis, check to measure Glaukos Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glaukos Corp is operating at the current time. Most of Glaukos Corp's value examination focuses on studying past and present price action to predict the probability of Glaukos Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glaukos Corp's price. Additionally, you may evaluate how the addition of Glaukos Corp to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance |
Is Glaukos Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Glaukos Corp. If investors know Glaukos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Glaukos Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 18.963 | Earnings Share (2.88) | Revenue Per Share 6.681 | Quarterly Revenue Growth 0.159 | Return On Assets (0.08) |
The market value of Glaukos Corp is measured differently than its book value, which is the value of Glaukos that is recorded on the company's balance sheet. Investors also form their own opinion of Glaukos Corp's value that differs from its market value or its book value, called intrinsic value, which is Glaukos Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Glaukos Corp's market value can be influenced by many factors that don't directly affect Glaukos Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Glaukos Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Glaukos Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Glaukos Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.